BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 34428558)

  • 1. Structural principles of insulin formulation and analog design: A century of innovation.
    Jarosinski MA; Dhayalan B; Chen YS; Chatterjee D; Varas N; Weiss MA
    Mol Metab; 2021 Oct; 52():101325. PubMed ID: 34428558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of insulin development: focus on key parameters.
    Tibaldi JM
    Adv Ther; 2012 Jul; 29(7):590-619. PubMed ID: 22843207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of non-standard insulin analogs for the treatment of diabetes mellitus.
    Pandyarajan V; Weiss MA
    Curr Diab Rep; 2012 Dec; 12(6):697-704. PubMed ID: 22983891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Horizons: Next-Generation Insulin Analogues: Structural Principles and Clinical Goals.
    Jarosinski MA; Chen YS; Varas N; Dhayalan B; Chatterjee D; Weiss MA
    J Clin Endocrinol Metab; 2022 Mar; 107(4):909-928. PubMed ID: 34850005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes?
    Maiorino MI; Petrizzo M; Capuano A; Giugliano D; Esposito K
    Expert Opin Biol Ther; 2014 Jun; 14(6):799-808. PubMed ID: 24673155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin preparations with prolonged effect.
    Owens DR
    Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S5-14. PubMed ID: 21668337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthetic Human Insulin and Insulin Analogs.
    Rodbard HW; Rodbard D
    Am J Ther; 2020; 27(1):e42-e51. PubMed ID: 31876563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practice.
    Goldman J; Kapitza C; Pettus J; Heise T
    Curr Med Res Opin; 2017 Oct; 33(10):1821-1831. PubMed ID: 28537449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution of insulin therapy in diabetes mellitus.
    Heile M; Schneider D
    J Fam Pract; 2012 May; 61(5 Suppl):S6-12. PubMed ID: 22577636
    [No Abstract]   [Full Text] [Related]  

  • 10. A review of a family of ultra-rapid-acting insulins: formulation development.
    Krasner A; Pohl R; Simms P; Pichotta P; Hauser R; De Souza E
    J Diabetes Sci Technol; 2012 Jul; 6(4):786-96. PubMed ID: 22920803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closer to ideal insulin action: ultra fast acting insulins.
    Cengiz E
    Panminerva Med; 2013 Sep; 55(3):269-75. PubMed ID: 24088800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-hundred year evolution of prandial insulin preparations: From animal pancreas extracts to rapid-acting analogs.
    Bolli GB; Porcellati F; Lucidi P; Fanelli CG; Owens DR
    Metabolism; 2022 Jan; 126():154935. PubMed ID: 34762931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding concentrated insulins: a systematic review of randomized controlled trials.
    Ovalle F; Segal AR; Anderson JE; Cohen MR; Morwick TM; Jackson JA
    Curr Med Res Opin; 2018 Jun; 34(6):1029-1043. PubMed ID: 29166786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gla-100 Development: a Story of 'Serendipitous' Disruptive Innovation.
    Badgandi M; Negalur V; Reddy PS; Venkataraman S; Kota S; Barman KK; Jayaprassad V; Pasha MY; Sruthisri P; Mohan V
    J Assoc Physicians India; 2020 Dec; 68(12[Special]):13-17. PubMed ID: 33247658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
    Ozawa H; Murai Y; Ozawa T
    Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin analogs--is there a compelling case to use them? No!
    Davidson MB
    Diabetes Care; 2014 Jun; 37(6):1771-4. PubMed ID: 24855160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Evolution of Insulin and How it Informs Therapy and Treatment Choices.
    Hirsch IB; Juneja R; Beals JM; Antalis CJ; Wright EE
    Endocr Rev; 2020 Oct; 41(5):733-55. PubMed ID: 32396624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Basal insulins.
    Mora PF
    J Fam Pract; 2017 Oct; 66(10 Suppl):S7-S11. PubMed ID: 28991931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin analogs: Glimpse on contemporary facts and future prospective.
    Sharma AK; Taneja G; Kumar A; Sahu M; Sharma G; Kumar A; Sardana S; Deep A
    Life Sci; 2019 Feb; 219():90-99. PubMed ID: 30639280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes.
    Heise T; Mathieu C
    Diabetes Obes Metab; 2017 Jan; 19(1):3-12. PubMed ID: 27593206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.